EUVIMEDEUVIMED entdecken
Crossref

Clinical and Radiographic Outcomes of Transcrestal Sinus Floor Elevation With RBH of 3–5 mm : A Retrospective Study

Qianhui Li iD, Mengyuan Zhang iD, Jiafei Sun, Yingjie Mao, Fuming He iD, Qianming Chen iD, Ping Sun

Clinical Implant Dentistry and Related Research · 2026

DOI: 10.1111/cid.70143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Implant Dentistry and Related Research, 2026. Verfasst von Qianhui Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, …. Hauptthemen laut MEDLINE: Sinus Floor Augmentation, Dental Implantation, Endosseous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Basic Public Welfare Research Program of Zhejiang Province, Research and Development Project of Stomatology Hospital Affiliated to Zhejiang University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the clinical and radiographic outcomes of transcrestal sinus floor elevation (TSFE) with simultaneous implant placement in sites with residual bone height (RBH) of 3–5 mm. Materials and Methods This retrospective cohort study included patients who underwent TSFE with simultaneous implant placement between December 2017 and September 2023. According to the intraoperative bone grafting status, patients were divided into two groups: the non‐grafting group and the grafting group (Bio‐Oss Collagen). Patient medical histories were collected, and radiographic parameters were measured at the following timepoints: preoperative (T0), immediate postoperative (T1), healing phase (T2, 4–6 months postoperatively), and follow‐up period (T3, 1–6 years postoperatively). Implant survival rate, complication‐free survival rate, incidence of sinus membrane perforation (SMP), endo‐sinus bone gain volume (ESBGV), endo‐sinus bone gain height (ESBGH), marginal bone loss (MBL), apical bone height (ABH), and mean cost of treatment were evaluated. A linear mixed model (LMM) regression was employed to identify key determinants influencing endo‐sinus bone augmentation following TSFE.

Results

Sixty‐six dental implants placed in 57 patients were included (non‐grafting group: 26 implants in 21 patients; grafting group: 40 implants in 36 patients). After the 1‐ to 6‐year follow‐up, the survival rate of implants was 100% in two groups ( p > 0.05) and complication‐free survival rate was 84.85% at implant level (non‐grafting group: 80.77%, grafting group: 87.50%; p > 0.05) and 82.46% at patient level (non‐grafting group: 76.19%, grafting group: 86.11%; p > 0.05). The incidence of SMP was 11.54% and 10.00% in non‐grafting and grafting groups, respectively ( p > 0.05). ESBGV, ESBGH, and ABH were significantly greater in the grafting group compared to the non‐grafting group ( p < 0.05). No significant differences in MBL were found ( p > 0.05). The total treatment cost was significantly lower in the non‐grafting group than in the grafting group ( p < 0.05), whereas no significant difference was found in retreatment costs between the groups ( p > 0.05). The LMM regression results showed that the core determinant of ESBGV was postoperative maxillary sinus augmentation volume ( p < 0.05).

Conclusion

Within the limitations of this study, TSFE with simultaneous implant placement demonstrated medium‐ to long‐term stable clinical and radiographic outcomes in the posterior atrophic maxilla ridges with RBH ranging from 3 to 5 mm regardless of bone grafting. While the grafting strategy significantly enhanced endo‐sinus bone augmentation, the non‐grafted approach was associated with significantly lower overall treatment costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sinus Floor AugmentationDental Implantation, EndosseousHumansRetrospective StudiesFemaleMaleMiddle AgedTreatment OutcomeBone TransplantationBone SubstitutesDental ImplantsMineralsAdult

Stichwörter der Autor:innen

bone substitutescone‐beam computed tomographydental implantsmaxillary sinussinus floor augmentationtranscrestal sinus floor elevation

Substanzen

Bone SubstitutesBio-OssDental ImplantsMinerals

Autor:innen und Institutionen

  • Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Hangzhou, China.

ORCID-Profile: Qianhui Li, Mengyuan Zhang, Fuming He, Qianming Chen

Förderung

  • Basic Public Welfare Research Program of Zhejiang Province
  • Research and Development Project of Stomatology Hospital Affiliated to Zhejiang University School of Medicine

Zitieren

APA

Li, Q., Zhang, M., Sun, J., Mao, Y., He, F., Chen, Q., & Sun, P. (2026). Clinical and Radiographic Outcomes of Transcrestal Sinus Floor Elevation With RBH of 3–5 mm : A Retrospective Study. Clinical Implant Dentistry and Related Research. https://doi.org/10.1111/cid.70143

Vancouver

Li Q, Zhang M, Sun J, Mao Y, He F, Chen Q, et al. Clinical and Radiographic Outcomes of Transcrestal Sinus Floor Elevation With RBH of 3–5 mm : A Retrospective Study. Clinical Implant Dentistry and Related Research. 2026. doi:10.1111/cid.70143

BibTeX
@article{Li2026,
  author = {Li, Qianhui and Zhang, Mengyuan and Sun, Jiafei and Mao, Yingjie and He, Fuming and Chen, Qianming and Sun, Ping},
  title = {Clinical and Radiographic Outcomes of Transcrestal Sinus Floor Elevation With RBH of 3–5 mm : A Retrospective Study},
  journal = {Clinical Implant Dentistry and Related Research},
  year = {2026},
  doi = {10.1111/cid.70143}
}
Kostenlos starten →